Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBluefield Solar Regulatory News (BSIF)

Share Price Information for Bluefield Solar (BSIF)

Share Price is delayed by 15 minutes
Get Live Data
91.50    0.00 (0.00%)
Bid:
91.40
Ask:
91.50
Spread: 0.10 (0.109%)
Market Cap: £541.75m
BSIF Live PriceLast checked at - London Stock Exchange

Intraday Bluefield Solar Share Chart

Update research from QuotedData

12 Jan 2023 12:32

RNS Number : 5738M
Bluefield Solar Income Fund Limited
12 January 2023
 

 

 

 

Bluefield Solar Income Fund - Update research from QuotedData

12th January 2023

Politicians cloud otherwise bright future

As we describe in this note, there are a lot of moving parts that go into making Bluefield Solar Income Fund (BSIF) run smoothly. However, the net result should be a fund that offers investors attractive, relatively predictable and largely inflation-linked levels of income, plus the prospect of capital growth.

In recent months, the actions of successive UK governments and sharp increases in bond yields have unnerved investors in the sector. This has created some discount volatility for BSIF and its peers.

However, we think that this is a short-term problem. We note that BSIF latest solar plants have secured long-term, predictable, and inflation-linked income through the government's current support mechanism for the industry (which uses contracts for difference - CfDs) - see page 5.

With greater clarity on windfall taxes and the impact of higher discount rates, BSIF's shares are trading closer to net asset value (NAV). The chairman says BSIF's latest acquisition (see page 14) helps underpin the board's confidence in delivering its dividend target of 8.4p per share for the current financial year. We see no reason why BSIF's shares should not return to trading at a premium to NAV.

Full Research:

https://quoteddata.com/research/bluefield-solar-income-fund-politicians-cloud-bright-future-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on Bluefield Solar Income Fund Limited and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUUOURORUAAAR
Date   Source Headline
6th Nov 20252:40 pmRNSForm 8.3 - Bluefield Solar Income Fund Ltd
6th Nov 20252:39 pmEQSForm 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
6th Nov 20251:41 pmGNWForm 8.3 - Bluefield Solar Income Fund Ltd
6th Nov 202512:56 pmRNSForm 8.3 - Bluefield Solar Income Fund - Replace
6th Nov 202512:56 pmRNSForm 8.3 - Bluefield Solar Income Fund - Replace
6th Nov 202512:16 pmGNWMan Group PLC : Form 8.3 - Bluefield Solar Income Fund Ltd
6th Nov 202512:00 pmRNSForm 8.3 - Bluefield Solar Income Fund Limited
6th Nov 202510:21 amRNSForm 8.3 - Bluefield Solar Income Fund Ltd
6th Nov 202510:15 amRNSForm 8.5 (EPT/RI) -Bluefield Solar Income Fund Ltd
5th Nov 20255:38 pmRNSForm 8.3 -Bluefield Solar Income Fund Ltd
5th Nov 20252:44 pmRNSForm 8.3 - Bluefield Solar Income Fund Limited
5th Nov 20259:47 amRNSForm 8.3 - Bluefield Solar Income Fund Ltd
5th Nov 20257:00 amRNSStrategic Review and Start of Formal Sale Process
4th Nov 20259:03 amRNSDirector Declaration
21st Oct 20257:40 amRNSFourth Interim Dividend - Replacement
21st Oct 20257:02 amRNSChanges to Director Roles and Responsibilities
21st Oct 20257:01 amRNSFourth Interim Dividend
21st Oct 20257:00 amRNSAnnual Report for the Year Ended 30 June 2025
2nd Oct 20257:00 amRNSNotice of Full Year Results
12th Sep 20252:30 pmRNSHolding(s) in Company
19th Aug 20257:00 amRNSUnaudited NAV, Dividend & Director Role Changes
18th Aug 20257:00 amRNSSigning of Phase Three of Strategic Partnership
30th May 20257:00 amRNSRevolving Credit Facility Reduced and Extended
15th May 20257:00 amRNSUnaudited NAV and Second Interim Dividend
27th Feb 20257:00 amRNSInterim Results to 31 December 2024
24th Feb 20257:00 amRNSCompletion of circa £300 million refinancing
19th Feb 202511:02 amRNSChange to Director Roles and Responsibilities
3rd Feb 20257:00 amRNSTotal Voting Rights
29th Jan 20257:00 amRNSNotice of Interim Results
28th Jan 20257:00 amRNSFirst Interim Dividend
20th Jan 202512:39 pmRNSHolding(s) in Company
17th Jan 202511:37 amRNSHolding(s) in Company
16th Jan 20254:27 pmRNSHolding(s) in Company
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:01 amRNSTotal Voting Rights
2nd Jan 20257:00 amRNSTransaction in Own Shares
31st Dec 20247:00 amRNSTransaction in Own Shares
30th Dec 20247:00 amRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
18th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.